State Board of Administration of Florida Retirement System’s Teva Pharmaceuticals TEVA Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Buy	69,381 +5,552	+9%	+$185K	﹤0.01%	1038
2026 Q1	$1.92M	Hold	63,829	–	–	﹤0.01%	1038
2025 Q4	$1.99M	Buy	63,829 +7,984	+14%	+$197K	﹤0.01%	1033
2025 Q3	$1.13M	Buy	55,845 +400	+0.7%	+$7.03K	﹤0.01%	1202
2025 Q2	$929K	Buy	55,445 +762	+1%	+$12.3K	﹤0.01%	1260
2025 Q1	$840K	Hold	54,683	–	–	﹤0.01%	1260
2024 Q4	$1.21M	Hold	54,683	–	–	﹤0.01%	1158
2024 Q3	$985K	Hold	54,683	–	–	﹤0.01%	1243
2024 Q2	$889K	Sell	54,683 -7,335	-12%	-$113K	﹤0.01%	1249
2024 Q1	$549K	Buy	62,018 +7,335	+13%	+$92.5K	﹤0.01%	1485
2023 Q4	$571K	Buy	54,683 +3,600	+7%	+$33.6K	﹤0.01%	1532
2023 Q3	$521K	Sell	51,083 -10,935	-18%	-$102K	﹤0.01%	1521
2023 Q2	$467K	Hold	62,018	–	–	﹤0.01%	1614
2023 Q1	$549K	Hold	62,018	–	–	﹤0.01%	1536
2022 Q4	$566K	Hold	62,018	–	–	﹤0.01%	1528
2022 Q3	$500K	Buy	62,018 +397	+0.6%	+$3.51K	﹤0.01%	1597
2022 Q2	$463K	Hold	61,621	–	–	﹤0.01%	1693
2022 Q1	$579K	Hold	61,621	–	–	﹤0.01%	1703
2021 Q4	$494K	Hold	61,621	–	–	﹤0.01%	1824
2021 Q3	$600K	Hold	61,621	–	–	﹤0.01%	1730
2021 Q2	$610K	Hold	61,621	–	–	﹤0.01%	1753
2021 Q1	$711K	Hold	61,621	–	–	﹤0.01%	1616
2020 Q4	$595K	Hold	61,621	–	–	﹤0.01%	1683
2020 Q3	$555K	Hold	61,621	–	–	﹤0.01%	1600
2020 Q2	$760K	Hold	61,621	–	–	﹤0.01%	1413
2020 Q1	$553K	Hold	61,621	–	–	﹤0.01%	1459
2019 Q4	$604K	Buy	61,621 +5,140	+9%	+$45.9K	﹤0.01%	1629
2019 Q3	$389K	Buy	56,481 +7,300	+15%	+$55.9K	﹤0.01%	1811
2019 Q2	$454K	Hold	49,181	–	–	﹤0.01%	1773
2019 Q1	$771K	Hold	49,181	–	–	﹤0.01%	1543
2018 Q4	$758K	Buy	49,181 +1,681	+4%	+$34.5K	﹤0.01%	1495
2018 Q3	$1.02M	Buy	47,500 +2,000	+4%	+$46.4K	﹤0.01%	1468
2018 Q2	$1.11M	Hold	45,500	–	–	﹤0.01%	1431
2018 Q1	$778K	Buy	45,500 +2,689	+6%	+$52.5K	﹤0.01%	1584
2017 Q4	$811K	Buy	42,811 +200	+0.5%	+$3.01K	﹤0.01%	1599
2017 Q3	$750K	Hold	42,611	–	–	﹤0.01%	1655
2017 Q2	$1.42M	Buy	42,611 +611	+1%	+$18.9K	﹤0.01%	1237
2017 Q1	$1.35M	Hold	42,000	–	–	﹤0.01%	1277
2016 Q4	$1.52M	Buy	+42,000	New	+$1.68M	﹤0.01%	1214

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Board of Administration of Florida Retirement System's TEVA Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System increased its Teva Pharmaceuticals (TEVA) stake by 8.7% in Q2 2026, buying an estimated $185K and bringing the position to 69,381 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

State Board of Administration of Florida Retirement System first reported a position in TEVA in Q4 2016 and has held it in 39 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

State Board of Administration of Florida Retirement System held 69,381 shares of Teva Pharmaceuticals worth $2.35M as of Q2 2026.
State Board of Administration of Florida Retirement System bought 5,552 Teva Pharmaceuticals shares in Q2 2026, an estimated $185K.
Teva Pharmaceuticals made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #1038 holding.
State Board of Administration of Florida Retirement System first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.